We recently introduced readers of The Microbiome Snapshot to our sister company, CoreBiome, a privately-held, Minnesota-based microbiome analysis company that accelerates discovery for customers in the pharmaceutical, agricultural, environmental and research communities. We are continuing this story via a podcast with CoreBiome co-founder, Dr. Dan Knights. In this new podcast, Dr. Knights speaks to us about why the microbiome is so different from the human genome, what answers microbiome research can provide for wellness and disease that we can’t find elsewhere, and what advice he would give an epidemiologist who is looking to add a microbiome component to their project.Read More
DNA Genotek's Sample Collection Blog
One of the things I like most about my job at DNA Genotek is the opportunity to speak with customers who are breaking new ground in the fields of genomics and microbiome. In the past 9 years, I’ve spoken with hundreds of customers and written blogs about dozens of them. I recently had a chance to speak with Sergey Musienko, CEO of Atlas Biomed. Atlas Biomed, based in the UK, is defining a new market by offering direct-to-consumer products for both genomic and microbiome analysis within the European market. I wanted to share the conversation I had with Sergey about how Atlas Biomed is defining this new market, the challenges he faces and what he is learning along the way.Read More
The issue of concussions has attracted considerable media coverage in recent years. According to the Centers for Disease Control and Prevention, 153 people in the United States die every day from traumatic brain injuries (TBI) that include concussions. Those who survive can face effects that last a few days, or the rest of their lives. Effects of concussions can include impaired thinking or memory, movement, sensation (e.g., vision or hearing), or emotional functioning (e.g., personality changes, depression). In 2013, about 2.8 million TBI-related emergency department visits, hospitalizations, and deaths occurred in the United States.Read More
At DNA Genotek, we are continually being introduced to new and exciting research projects through the innovative work of our customers. I recently came across a particularly interesting study which is known as one of the largest metastatic breast cancer studies to date. The study, led by the Broad Institute of MIT and Harvard University, is called the Metastatic Breast Cancer (MBC) Project. This project caught my attention because of their unique approach to patient recruitment and engagement which is garnering media coverage across the country.Read More
There are few subjects that have received as much coverage in the genetics space in recent months as precision medicine. The conversation about precision medicine began many years ago but the recent launch of the Precision Medicine Initiative in the United States and similar projects in many other countries around the world has brought this topic to the main stream. There remain many questions about the implementation of precision medicine with people looking to doctors and clinicians as the first and most obvious choice as the point of contact for patients. However, one group in British Columbia, Canada is looking to local community pharmacists to bring precision medicine closer to those who can benefit most.Read More
A year or so ago, Nature Communications published an article that highlighted how researchers in the Department of Genetics at the University of Leicester successfully used DNA from saliva to help identify the remains of King Richard III and solved a 500 year old mystery. The story behind the recovery of the remains and their subsequent identification as those of the missing king is an interesting one that combines ancient DNA analysis with modern DNA from saliva.Read More
Front Line Genomics is a new company with a mission to help bring the benefits of genomics to patients faster. DNA Genotek interviewed Richard Lumb, CEO of Front Line Genomics about the company, its social mission and their upcoming Festival of Genomics in Boston.Read More
In the summer of 2011 we wrote about an exciting project out of the United Kingdom that selected Oragene collection kits for a study that aimed to unlock genetic changes behind development disorders. The Deciphering Developmental Disorders (DDD) study is a direct collaboration with all twenty-three of the NHS Clinical Genetics Services from across the UK together with the Wellcome Trust Sanger Institute.
Everyone at DNA Genotek is familiar with event-based collections. We’ve worked with dozens of customers over the years to help facilitate collecting samples for breast cancer, epilepsy, HLA-typing and more. Recently, our products were used in an event-based collection to support education and provide information on how genes are linked to our ancestry. The New Horizons Festival (NHF) was held at Erasmus MC and several other public locations in Rotterdam, the Netherlands on September 26, 2014 and over 1,500 people participated. The purpose of the event was to make science accessible and attractive to the general public by merging science with art and music to create a fun, interactive event.
In a recent article on The Genetic Link, we talked about going global and how our regulatory strategy helps support our customers who are conducting genetic research. Today, I am focusing on the work we do to ensure our products' compatibility with the technologies our genetic research and testing customers use in the field and in their labs.